echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > A&R: Antibodies to cartilage oligomeric matrix protein (COMP) are pathogenic in mice and may be clinically relevant to rheumatoid arthritis

    A&R: Antibodies to cartilage oligomeric matrix protein (COMP) are pathogenic in mice and may be clinically relevant to rheumatoid arthritis

    • Last Update: 2022-08-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Objective : Cartilage oligomeric matrix protein (COMP) is an autoantigen in rheumatoid arthritis (RA) and experimental models of arthriti.


    Objective Cartilage oligomeric matrix protein (COMP) is an autoantigen in rheumatoid arthritis (RA) and experimental models of arthriti.


    Methods We investigated the pathogenicity of monoclonal anti- COMP antibodies in mice using passive transfer experiments and explored the interaction of anti- immune COMP antibodies with cartilage using immunohistochemical stainin.


    Results The murine monoclonal anti- COMP antibody 15A11 induced arthritis in naive mi.


    Conclusions The findings provide a structural basis for binding pathogenic anti- COMP antibodies to cartila.


    Source: Ge,.


    Ge,.
    , Tong,.
    , Lönnblom,.
    , Liang,.
    , Cai,.
    , Fahlquist-Hagert,.
    , Li,.
    , Kastbom,.
    , Gjertsson,.
    , Dobritzsch, .
    and Holmdahl,.

    (2022), Antibodies to Cartilage Oligomeric Matrix Protein Are Pathogenic in Mice and May Be Clinically Relevant in Rheumatoid Arthrit.

    Arthritis Rheumatol, 74: 961-97https://d.

    org/11002/a.

    42072 https://d.

    org/11002/a.

    42072 Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.